On December 31, Eli Lilly and (LLY) had a market capitalization of $960.4B, based on 898M shares at a price of $1,069.51.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2025 | $1,069.51 | 65,881,000 | 898,002,000 | $960,424,902,826.20 |
November 2025 | $1,070.30 | 87,069,500 | 898,002,000 | $961,130,822,198.40 |
October 2025 | $857.45 | 78,563,800 | 898,002,000 | $769,993,700,704.20 |
September 2025 | $758.22 | 73,098,300 | 898,800,000 | $681,486,338,400.00 |
August 2025 | $727.99 | 140,434,800 | 898,800,000 | $654,316,243,560.00 |
July 2025 | $733.82 | 71,862,600 | 898,800,000 | $659,557,326,120.00 |
June 2025 | $772.95 | 64,392,100 | 899,793,000 | $695,492,030,033.10 |
May 2025 | $731.44 | 107,206,000 | 899,793,000 | $658,144,771,878.60 |
April 2025 | $889.53 | 84,268,200 | 899,793,000 | $800,397,186,296.40 |
March 2025 | $817.26 | 73,350,300 | 900,604,000 | $736,027,444,919.20 |
February 2025 | $910.99 | 69,233,700 | 900,604,000 | $820,439,256,631.20 |
January 2025 | $801.20 | 77,095,400 | 900,604,000 | $721,567,797,397.20 |
December 2024 | $762.60 | 67,169,200 | 903,158,000 | $688,748,381,115.80 |
November 2024 | $785.67 | 99,593,100 | 903,158,000 | $709,580,352,596.40 |
October 2024 | $818.28 | 68,789,500 | 903,158,000 | $739,037,844,240.20 |
September 2024 | $873.71 | 58,008,800 | 905,000,000 | $790,703,749,000.00 |
August 2024 | $946.76 | 79,125,600 | 905,000,000 | $856,820,334,000.00 |
July 2024 | $792.06 | 72,471,200 | 905,000,000 | $716,811,494,500.00 |
June 2024 | $891.63 | 50,459,200 | 904,200,000 | $806,213,202,300.00 |
May 2024 | $807.88 | 58,803,000 | 904,200,000 | $730,487,627,760.00 |
April 2024 | $767.93 | 57,419,600 | 904,200,000 | $694,362,125,160.00 |
March 2024 | $764.84 | 58,751,800 | 903,800,000 | $691,264,832,260.00 |
February 2024 | $740.97 | 76,662,600 | 903,800,000 | $669,690,583,980.00 |
January 2024 | $633.61 | 61,985,100 | 903,800,000 | $572,660,062,060.00 |
December 2023 | $572.09 | 56,875,500 | 903,980,000 | $517,156,562,230.00 |